BDX
Becton, Dickinson·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 2
Dividend Aristocrat
High Cash/net Profit Ratio
Price Hits 52-week Low
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BDX
Becton, Dickinson And Company
A leading global medical technology company that develops medical supplies, devices, instrument systems and reagents used by healthcare institutions
Healthcare Equipment and Supplies
--
09/25/1963
New York Stock Exchange
72,000
09-30
Common stock
1 Becton Drive
Franklin Lakes
New Jersey 07417-1880
Manufacturing and sales of healthcare equipment
Becton, Dickinson And Company was incorporated in November 1906 under the laws of the State of New Jersey. The Company is a global medical technology company engaged in the development, manufacture and sale of various medical supplies, equipment, laboratory equipment and diagnostic products used by medical institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the public. The Company provides customer solutions focused on improving drug management and patient safety; supporting infection prevention practices; equipping surgery and interventional surgery; improving drug delivery; assisting in anesthesia care; enhancing the diagnosis of infectious diseases and cancer; promoting cell research and application; and supporting the management of diabetes.
Earnings Call
Q3/2025
Estimate EPS3.4
Actual EPS3.68
Estimate Revenue5.49B
Actual Revenue5.50B
Becton, Dickinson's Q3 2025: Unpacking Contradictions in Tariffs, Growth, and Strategic Direction
Aug 07,2025 10:04
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BDX has released its 2025 Q4 earnings. EPS was reported at 3.96, versus the expected 3.91, beating expectations. The chart below visualizes how BDX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BDX has released its 2025 Q4 earnings report, with revenue of 5.89B, reflecting a YoY change of 8.35%, and net profit of 493.00M, showing a YoY change of 23.25%. The Sankey diagram below clearly presents BDX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
